VIPomas: An update in diagnosis and management in a series of 11 patients

Hepato-Gastroenterology

Volumn 52, Issue 64, 2005, Pages 1259-1265

  Nikou, George C ^a,c   Toubanakis, Christos ^a   Nikolaou, Panagiota ^a   Giannatou, Eleanna ^a   Safioleas, Michael ^a   Mallas, Elias ^b   Polyzos, Aris ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c NONE   (Greece)

Author keywords

Chemotherapy; Chromogranin A; Endoscopic Ultrasound; OCTREOSCAN; Octreotide; Pancreatic Endocrine Tumors; Somatostatin analogues; VIP; VIPomas

Indexed keywords

CHROMOGRANIN A; CISPLATIN; ETOPOSIDE; FLUOROURACIL; GASTRIN; OCTREOTIDE; PANCREAS POLYPEPTIDE; PENTETATE INDIUM IN 111; PENTETREOTIDE; PEPTIDE HORMONE; SOMATOSTATIN DERIVATIVE; STREPTOZOCIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ABDOMINAL ANGIOGRAPHY; ACHLORHYDRIA; ADOLESCENT; ADULT; AGED; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; DIARRHEA; DISEASE ACTIVITY; DISEASE COURSE; DUODENUM; EARLY DIAGNOSIS; ENDOSCOPIC ECHOGRAPHY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOKALEMIA; LIVER METASTASIS; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS RESECTION; PANCREAS TUMOR; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RARE DISEASE; RETROPERITONEUM; SHORT SURVEY; SURVIVAL; VIPOMA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS, HORMONAL; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OCTREOTIDE; PANCREATECTOMY; PANCREATIC NEOPLASMS; SURVIVAL RATE; VIPOMA;

EID: 21744461435     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (28)

1. Jensen R: Pancreatic endocrine tumors. Recent advances. Ann Oncol 1999; 10(Suppl 4):170-176.
2. Lo CY, van Heerden JA, Thompson GB, et al: Islet cell carcinoma of the pancreas. World J Surg 1996; 20:878-883.
3. Gumbs AA, Moore PS, Falconi M, et al: Review of the clinical, histological and molecular aspects of pancreatic endocrine neoplasms. J Surg Oncol 2002; 81:45-53.
4. Verner JV, Morrison AB: Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med 1958; 25:374-380.
5. Solcia E, Rindi G, Paolotti D, et al: Clinicopathological profile as a basis for classification of the endocrine tumors of the gastroenteropancreatic tract. Ann Oncol 1999; 10(Suppl 2):S9-S15.
6. Soga J, Yakuwa Y: VIPoma/diarrheogenic syndrome: A statistical evaluation of 241 reported cases. J Exp Clin Cancer Res 1998; 17:389.
7. Bloom SR, Christofides ND, Delamarter J, et al: Diarrhea in vipoma patients associated with cosecretion of a second active peptide (peptide histidine isoleukine) explained by single coding gene. Lancet 1983; 2:1163.
8. Kane MG, O'Dorisio TM, Kregs GJ: Production of secretory diarrhea by intravenous infusion of vasoactive intestinal polypeptide. N Engl J Med 1983; 309:1482.
9. Calam J, Yangou Y, Nikou GC, et al: Effects of prepro-VTP derived peptides on ileal output. Gastroenterology 1990; 98:505-508.
10. Kregs GJ: Comparison of the effect of VIP and PHI on water and ion movement in the canine jejunum in vivo. Gastroenterol Clin Biol 1984; 8:868.
11. Long RG, Bryant MG, Mitchell SJ, et al: Clinicopathological study of pancreatic and ganglioneuroblastoma tumors secreting vasoactive intestinal polypeptide (vipomas). BMJ 1981; 282:1767-1771.
12. Smith SL, Branton S, Avino A, et al: Vasoactive intestinal polypeptide screening islet cell tumors: A 15-year experience and review of the literature. Surgery 1998; 124:1050-1055.
13. Deftos LJ: Chromogranin-A, its role in endocrine function and as an endocrine and neuroendocrine tumor marker. Endocrine Review 1991; 12:181-187.
14. Bajetta E, Ferrari L, Merlonetti A, et al: Chromogranin-A, neuronspecific enolase, carcinoembryonic antigen and hydroxi indole acetic acid evaluation in patients with neuroendocrine tumors. Cancer 1999; 86:585-865.
15. Tomasseti P, Migliori M, Simoni P, Casadei R, et al: Diagnostic value of plasma chromogranin A in neuroendocrine tumors. Eur J Gastroenterol Hepatol 2001; 13:55-58.
16. Wiedenmann B, Jensen RT, Mignon M, et al: Preoperative diagnosis and surgical management of neuroendocrine gastropancreatic tumors. World J Surg 1998; 22:309-318.
17. Nikou GC, Kyriaki D, Kitsou E, et al: Somatostatin receptor imaging in the diagnosis and management of gut endocrine tumors. Hell J Gastroenterol 1995; 8:312-318.
18. Krenning EP, de Jong M, Kooij PPM, Breeman WAP, et al: Radiolabelled somatostatin analogues for peptide receptor scintigraphy and radionuclide therapy. Ann Oncol 1999; 10(Suppl 2):S23-S29.
19. De Herder WW, Lamberts SWJ: Somatostatin and somatostatin analogues: diagnostic and therapeutic uses. Curr Opin Oncol 2002; 14:53-57.
20. Bansal R, Tierney W, Carpenter S, et al: Cost effectiveness of EUS for preoperative localisation of pancreatic endocrine tumors. Gastrointest Endosc 1999; 49:19-25.
21. Zimmer T, Scherubl H, Faiss S, et al: Enoscopic ultrasonography of neuroendocrine tumors. Digestion 2000; 62(Suppl 1):45-50.
22. Hellman P, Andersson M, Rastad J, et al: Surgical strategy for large or malignant endocrine pancreatic tumors. World J Surg 2000; 24:1353-1360.
23. Norton JA, Warren RS, Kelly MG, et al: Aggressive surgery for metastatic liver neuroendocrine tumors. Surgery 2003; 134:1057-1063.
24. Rindi G, Kloppel G: Endocrine tumors of the gut and pancreas. Tumor biology and classification. Neuroendocrinology 2004; 80(Suppl 1):12-15.
25. Nikou GC, Dossios Th, Samolada O, et al: Treatment of metastatic carcinoids. Ten years experience with octreotide, Hell J Gastroenterol 1996; 9:317-321.
26. Oberg K, Kvols L, Caplin M, et al: Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. Ann Oncol 2004; 15:966-973.
27. O'Toole D, Hentic O, Corcos O, Ruszniewski P: Chemotherapy for Gastroenteropancreatic tumors. Neuroendocrinology 2004; 80(Suppl 1):79-84.
28. Nguyen H, Backes B, Lammert F, et al: Long-term survival after diagnosis of hepatic metastatic vipoma. Dig Dis Sci 1999; 44:1148-1155.